Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 20 04:00PM ET
3.19
Dollar change
+0.14
Percentage change
4.59
%
Index- P/E- EPS (ttm)-5.31 Insider Own0.35% Shs Outstand20.51M Perf Week-10.64%
Market Cap65.43M Forward P/E- EPS next Y-4.56 Insider Trans-6.56% Shs Float20.44M Perf Month25.59%
Income-102.09M PEG- EPS next Q-1.11 Inst Own13.82% Short Float1.23% Perf Quarter-8.87%
Sales0.00M P/S- EPS this Y33.44% Inst Trans- Short Ratio1.02 Perf Half Y-33.02%
Book/sh2.81 P/B1.14 EPS next Y9.90% ROA-72.19% Short Interest0.25M Perf Year-66.77%
Cash/sh2.26 P/C1.41 EPS next 5Y21.22% ROE-103.11% 52W Range2.20 - 10.70 Perf YTD-66.52%
Dividend Est.- P/FCF- EPS past 5Y35.36% ROI-167.16% 52W High-70.19% Beta0.64
Dividend TTM- Quick Ratio2.22 Sales past 5Y0.00% Gross Margin- 52W Low44.70% ATR (14)0.36
Dividend Ex-Date- Current Ratio2.22 EPS Y/Y TTM0.58% Oper. Margin- RSI (14)46.59 Volatility9.13% 10.06%
Employees104 Debt/Eq0.28 Sales Y/Y TTM- Profit Margin- Recom1.50 Target Price23.21
Option/ShortNo / Yes LT Debt/Eq0.13 EPS Q/Q-81.65% Payout- Rel Volume0.09 Prev Close3.05
Sales Surprise-3.21% EPS Surprise11.11% Sales Q/Q- EarningsNov 06 AMC Avg Volume246.84K Price3.19
SMA20-6.01% SMA50-6.99% SMA200-34.70% Trades Volume21,556 Change4.59%
Date Action Analyst Rating Change Price Target Change
Jan-04-23Upgrade Societe Generale Hold → Buy
Dec-16-22Downgrade Goldman Neutral → Sell
May-10-22Downgrade Goldman Buy → Neutral $6 → $1.50
Sep-14-21Upgrade Societe Generale Hold → Buy
Jan-22-21Downgrade Societe Generale Hold → Sell
Nov-02-20Upgrade Societe Generale Sell → Hold
Aug-06-20Downgrade Societe Generale Buy → Sell
Aug-05-20Reiterated H.C. Wainwright Buy $25 → $14
Mar-17-20Downgrade Stifel Buy → Hold $18 → $6
Jan-09-20Upgrade Stifel Hold → Buy $10 → $18
Dec-12-24 09:59AM
Dec-11-24 04:05PM
Dec-02-24 04:30PM
Nov-11-24 04:30PM
Nov-06-24 04:30PM
08:31AM Loading…
Oct-24-24 08:31AM
Oct-22-24 04:45PM
Oct-18-24 04:30PM
Oct-14-24 04:30PM
Sep-23-24 04:30PM
Sep-04-24 04:30PM
Aug-02-24 04:30PM
Jul-30-24 08:55PM
05:30PM
04:30PM
01:30AM Loading…
Jul-29-24 01:30AM
Jul-08-24 04:30PM
Jun-05-24 04:30PM
Jun-04-24 04:30PM
May-31-24 09:51AM
May-30-24 04:30PM
May-17-24 04:30PM
May-16-24 04:30PM
May-09-24 04:30PM
May-07-24 11:53PM
04:30PM
Apr-25-24 04:30PM
Apr-04-24 04:43PM
Mar-08-24 11:01AM
09:33AM
10:52PM Loading…
Mar-07-24 10:52PM
04:30PM
Mar-04-24 04:30PM
Feb-20-24 04:30PM
Jan-16-24 04:30PM
Dec-04-23 04:30PM
Nov-09-23 04:30PM
Nov-06-23 04:30PM
Nov-02-23 04:30PM
Oct-31-23 04:30PM
Oct-27-23 04:30PM
Oct-16-23 02:00AM
Oct-05-23 04:30PM
Sep-05-23 04:30PM
Jul-31-23 04:25PM
Jul-25-23 04:30PM
Jul-19-23 04:30PM
Jul-10-23 04:30PM
Jun-16-23 04:30PM
Jun-08-23 04:30PM
Jun-06-23 05:00PM
May-10-23 05:30PM
May-09-23 04:30PM
May-04-23 04:30PM
Apr-19-23 05:09PM
Apr-12-23 04:30PM
Mar-24-23 04:30PM
Mar-13-23 01:30AM
Mar-07-23 04:30PM
Mar-02-23 05:30PM
04:30PM
Feb-27-23 01:30AM
Feb-21-23 04:30PM
Feb-10-23 04:30PM
Jan-23-23 04:30PM
Jan-04-23 04:30PM
Dec-23-22 01:30AM
Dec-08-22 04:30PM
Nov-22-22 04:30PM
Nov-09-22 01:30AM
Nov-03-22 04:30PM
Oct-31-22 04:30PM
Oct-20-22 04:30PM
Oct-03-22 04:30PM
Sep-21-22 05:45PM
Sep-07-22 04:30PM
Sep-02-22 04:30PM
Aug-10-22 04:50PM
Aug-01-22 04:30PM
Jul-27-22 04:30PM
Jul-20-22 04:30PM
Jun-28-22 06:15PM
Jun-16-22 01:30AM
Jun-09-22 02:55AM
Jun-07-22 04:30PM
May-17-22 04:30PM
May-12-22 04:30PM
May-04-22 07:30PM
May-02-22 05:00PM
04:00PM
Apr-25-22 07:30PM
04:30PM
Apr-21-22 04:30PM
Apr-14-22 04:30PM
Mar-14-22 04:30PM
Mar-11-22 04:30PM
Mar-09-22 04:30PM
Mar-03-22 04:15PM
Feb-24-22 04:30PM
Feb-22-22 04:30PM
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stephane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mohideen PharisChief Medical OfficerNov 25 '24Sale0.57565322111,110Nov 27 04:15 PM
Mohideen PharisChief Medical OfficerNov 22 '24Sale0.53342181111,675Nov 27 04:15 PM
Mohideen PharisChief Medical OfficerNov 21 '24Sale0.542,3501,269112,017Nov 25 05:13 PM
Mohideen PharisChief Medical OfficerJul 29 '24Sale0.981,7851,74979,367Jul 31 05:32 PM
Mohideen PharisChief Medical OfficerMay 24 '24Sale1.3666089881,152May 29 04:15 PM
Mohideen PharisChief Medical OfficerMay 22 '24Sale1.3838252781,812May 29 04:15 PM
Tasse DanielCHIEF EXECUTIVE OFFICERMar 08 '24Buy0.8317,09414,18817,094Mar 11 04:15 PM
Ndu AdoraDirectorFeb 06 '24Buy0.891,8251,6241,825Feb 08 05:02 PM